Organ on chip is a recently developed multidisciplinary field in which human cell biology and microfluidics are combined on top of lab on chip architecture. Organ on a chip is one of the fastest growing application in the research areas in life science and pharmaceuticals industries. Organ on a chip is multi-channel microfluidic cell which stimulates the physiological response, activities and response of the organ and organ system, type of artificial organ.
Increasing in adoption organ on a chip will abolish the need for animals in toxin testing and drug development. Organ on a chip are used especially for research activity in the advanced biomedical engineering field such as bioMEMS, micro fabrication and microelectronics. Organ on chip creates new and innovative ways to culture cells and tissues which offer precise and continuous control during complete culturing process.
Organ on a chip have significant impact on the improvement on the predictability of drug screening models and personalized medicines. Multiple organs can be placed on the chip and re interconnected to model the dynamics of human organism which is possible due to 3D cell culture, micro fluids and 3D printing technologies which allow the cultivation of cells from patients which reflects phenotype or genotype.
Different companies and universities are continuously looking for better and new models in the development of drugs with collaboration with different manufacturing companies. In the long term, the organ on a chip technology helps in the advanced human based and personalized research and development of drugs.
Increase in innovation in drug development and growing prevalence of chronic disease such as respiratory disease, heart failure and other disease drive the market of organ on a chip kit market. Rising awareness among the population towards better healthcare devices propel the growth of organ on a chip kit market globally. Increase in healthcare expenditure and increase rate of organ transplant is expected to boost the demand of organ on a chip kit market during the forecast period. However, high cost associated with the kit of organ on chip and lack of adoption of innovative technology in the under developed economies hamper the growth of the organ on a chip kit market.
Organ on a chip kits are likely to contribute to reduction of animal tests in preclinical drug development and drug candidate screening may increase efficiency. Increase in growth for lungs and kidney based organ culture devices and increase in research activities on organ on chip devices are the major factors which drive the overall market of organ on a chip kit market.
On the basis of type of organ on a chip, lung on chip is expected to project the highest growth owing to increase in number of chronic disease and increase in awareness about the organ transplant during the forecast period.
On the basis of geography, global organ on a chip kit market is segmented into seven key regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan, and Middle East & Africa. North America is projected to hold largest shares in the global Organ on a Chip Kit Market primarily due to growing adoption of innovative technologies to cure disease which are chronic.
Increase in research and development activities and rise in healthcare applications in North America drive the market of organ on chip kit. Europe is anticipated to be the second in the revenues share. Asia Pacific region is anticipated to be the fastest growing region in organ on chip kit market owing to increase in investment in the research and development in the drug development and government initiative towards the improvement of healthcare expenditure. Latin America and Middle East & Africa is expected to show slow growth due to lack of awareness among the population and high cost associated with organ on a chip kit market in near future.
Some of the key players present in global organ on a chip kit market are Micronit Microtechnologies B.V, F. Hoffmann-La Roche Ltd, MIMETAS B.V., Nortis, CN Bio Innovations, TissUse GmbH, Koninklijke Philips N.V., and others
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
he global organ on a chip kit market is segmented by drug type and distribution channel:
Segmentation by Type
Segmentation by End User
Explore Similar Insights
Organ on a Chip Kit Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
